← European Medicine Shortage Tracker · all medicines

Apixaban shortage — availability across Europe

Apixaban currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: APIXABAN · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Apixaban, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2026-02-02 and has now been open for about 6 months. Where agencies state a cause, unexpectedly high demand lead with 2 of the 2 stated-cause reports. The furthest expected-resolution date currently on file is 2026-09-30; the earliest is 2026-09-30. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
ELIQUIS
+ 1 more products
ELIQUIS
2026-02-022026-09-30Elevata richiesta: forniture discontinue (carenza relativa solo al canale ospedaliero)
Alternatives: AIFA: an alternative treatment is available (ask your doctor).
register ↗

New register reports per month

2026-02: 12026-03: 02026-04: 12026-022026-04

Full report history (2 register entries)

Every individual register entry for Apixaban in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITELIQUISShortage2026-04-272026-09-30Elevata richiesta: forniture discontinue (carenza relativa s
🇮🇹 ITELIQUISShortage2026-02-022026-09-30Elevata richiesta: forniture discontinue (carenza relativa s

Frequently asked

Is Apixaban currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Apixaban shortage expected to end?

Agency prognoses on file range from 2026-09-30 to 2026-09-30. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Apixaban?

2 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Apixaban availability data come from?

Directly from the official medicines-agency register that lists Apixaban: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Apixaban — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/apixaban/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Apixaban availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/apixaban/">Apixaban shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Apixaban: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.